Hester Biosciences
1,644.40
+2.20(+0.13%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+0.13%
1M+2.54%
6M-8.54%
1Y-36.73%
5Y-7.11%
View Company Insightsright
More news about Hester Biosciences
09May 25
Hester Biosciences Declares Dividend Amidst Q4 Profit Decline
Hester Biosciences announced a ₹7 per share dividend despite a 73.74% drop in Q4 consolidated net profit to ₹13 million. Revenue increased by 4.05% to ₹72 crore, while sales decreased by 5.67%. EBITDA rose 11.29%, but operating profit halved. The company reported a significant increase in other income to ₹8.80 crore, potentially offsetting operational challenges.
Hester Biosciences
1,644.40
+2.20
(+0.13%)
1 Year Returns:-36.73%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)